These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
202 related articles for article (PubMed ID: 32684074)
41. A New Era in the Treatment of Thyroid Eye Disease. Patel A; Yang H; Douglas RS Am J Ophthalmol; 2019 Dec; 208():281-288. PubMed ID: 31377284 [TBL] [Abstract][Full Text] [Related]
42. Reduced risk of compressive optic neuropathy using orbital radiotherapy in patients with active thyroid eye disease. Shams PN; Ma R; Pickles T; Rootman J; Dolman PJ Am J Ophthalmol; 2014 Jun; 157(6):1299-305. PubMed ID: 24582992 [TBL] [Abstract][Full Text] [Related]
50. Teprotumumab for Thyroid-Associated Ophthalmopathy. Smith TJ; Kahaly GJ; Ezra DG; Fleming JC; Dailey RA; Tang RA; Harris GJ; Antonelli A; Salvi M; Goldberg RA; Gigantelli JW; Couch SM; Shriver EM; Hayek BR; Hink EM; Woodward RM; Gabriel K; Magni G; Douglas RS N Engl J Med; 2017 May; 376(18):1748-1761. PubMed ID: 28467880 [TBL] [Abstract][Full Text] [Related]
51. Teprotumumab as a Novel Therapy for Thyroid-Associated Ophthalmopathy. Smith TJ Front Endocrinol (Lausanne); 2020; 11():610337. PubMed ID: 33391187 [TBL] [Abstract][Full Text] [Related]
52. The role of intravenous methylprednisolone immunosuppression in the management of active thyroid eye disease. Tambe K; Bhargava J; Tripathi A; Gregory M; Burns J; Sampath R Orbit; 2010 Oct; 29(5):227-31. PubMed ID: 20812826 [TBL] [Abstract][Full Text] [Related]
54. Improvement of the MRI and clinical features of Asian Graves' ophthalmopathy by radiation therapy with steroids. Ma Z; Ozaki H; Ishikawa Y; Jingu K Jpn J Radiol; 2019 Aug; 37(8):612-618. PubMed ID: 31201593 [TBL] [Abstract][Full Text] [Related]
56. [Graves orbitopathy in pediatrics]. Mendoza F C; Lacourt R P Rev Med Chil; 2015 Aug; 143(8):1034-41. PubMed ID: 26436933 [TBL] [Abstract][Full Text] [Related]